Biocon Chief Kiran Mazumdar Shaw, 2 others join USIBC Board as vice chairs

Published On 2021-01-16 07:46 GMT | Update On 2021-01-16 07:46 GMT

Washington: Three top corporate leaders, including Milind Pant, CEO of Amway and Kiran Mazumdar-Shaw, executive chairperson, Biocon, have joined the 2021 Global Board of Directors of US India Business Council (USIBC) as vice chairs.

Besides Pant and Mazumdar-Shaw, Edward Knight, vice chair, Nasdaq has also been inducted in the leadership team of the leading business advocacy organisation.

The induction of three top corporate leaders strengthens the USIBC's leadership team as the Council engages a new US administration and advocates for stronger US-India commercial ties in an increasingly complex world.

As vice chairs, Pant, Mazumdar-Shaw and Knight will work with USIBC president Nisha Biswal and the Council's policy directors to elevate priorities in critical sectors and lead meetings between industry and government, the USIBC said in a statement.

"I'm pleased to see the US-India Business Council elevate as Vice Chairs these captains of industry and forward-thinking business leaders," said Vijay Advani, USIBC Board of Directors chairman and executive chairman, Nuveen.

"Their perspectives will be invaluable as USIBC charts a path forward in the post-pandemic era and continues its work to deepen the US-India partnership," he said.

Honoured to step into this new role as a vice chair for the US-India Business Council's Board of Directors, Pant said that during his time at Amway, he had greatly valued the USIBC and its role in helping American companies operating in India.

"I look forward to the continued engagement in strengthening the US-India bilateral relationship in this role," he said.

They will work to amplify the voice of industry on international trade and investment issues and emphasise the critical role that businesses can play in strengthening democratic institutions and combatting the global pandemic, the statement said.

"As the world recovers from the global pandemic, the economic relationship between the United States and India has never been more important to Nasdaq and its listed companies. The US-India Business Council is a vital link between the two business communities and a proven facilitator of a productive dialogue between the US and Indian Governments," Knight said.

Mazumdar-Shaw said, "I am honoured to serve as a Vice Chair at the USIBC Board of Directors. USIBC has been committed to enhancing US-India bilateral trade and in my new role, I look forward to forging collaborative initiatives in Pharma & Healthcare in the area of research, innovation and skill development between our two nations."

The pandemic has provided a unique opportunity for robust engagement between the two nations that can lead to knowledge sharing in digital healthcare, medical technologies and IP-led drug and vaccine innovation to deliver healthcare solutions that can boost mutually beneficial bilateral trade, Mazumdar-Shaw said.

Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Biocon Chief Kiran Mazumdar Shaw, 2 others join USIBC Board as vice chairs

Similar News

Roche gets negative EMA Committee opinion on Elevidys CMA for 3-7 year olds with Duchenne muscular dystrophy

Expert Committee Clears Ravenbhel to Begin Resmetirom Phase 3 Trial, Asks for BE Data First

Menopause relief drug: USFDA extends review period for Bayer Elinzanetant

Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimer's disease

Troikaa's Fast-Acting Paracetamol Shot Hits Regulatory Hurdle, CDSCO Panel Seeks More Data

Sanofi Sarclisa approved in EU for transplant-eligible newly diagnosed multiple myeloma

Pharma Firm Ignored Safety Gaps Before Deadly Blast, Paid Rs 32 Cr To Victims, Parliament Informed

GSK Blenrep combos approved in EU for treatment of relapsed/refractory multiple myeloma